S. Best

发表

Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists.

D. Auld, M. Webb, M. Ohlmeyer, 2011, Bioorganic & medicinal chemistry letters.

Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists.

D. Auld, M. Webb, M. Ohlmeyer, 2011, Bioorganic & medicinal chemistry letters.

Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 1.

C. Charrier, M. Craighead, J. Maclean, 2020, RSC medicinal chemistry.

Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitors.

C. Charrier, M. Craighead, D. Hughes, 2016, Bioorganic & medicinal chemistry letters.

Discovery and structure-activity relationships of a novel oxazolidinone class of bacterial type II topoisomerase inhibitors.

R. Newman, C. Charrier, M. Craighead, 2022, Bioorganic & medicinal chemistry letters.

REDX08608, a Novel, Potent and Selective, Reversible BTK Inhibitor with Efficacy and Equivalent Potency Against Wild-Type and Mutant C481S BTK

Victoria M Wright, Valentina Abet, J. Emmerich, 2016 .

Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria

Ralph C. Sigerson, R. Newman, C. Charrier, 2017, Antimicrobial Agents and Chemotherapy.

Biological profiling of novel tricyclic inhibitors of bacterial DNA gyrase and topoisomerase IV.

C. Charrier, N. R. Stokes, A. Ratcliffe, 2016, The Journal of antimicrobial chemotherapy.

Efficacy of a Novel Tricyclic Topoisomerase Inhibitor in a Murine Model of Neisseria gonorrhoeae Infection

C. Charrier, M. Craighead, H. Box, 2016, Antimicrobial Agents and Chemotherapy.

Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria

Ralph C. Sigerson, R. Newman, C. Charrier, 2017, Antimicrobial Agents and Chemotherapy.